Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture | Zendy

J. Brent Richards | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture

Author(s) -

J. Brent Richards

Publication year - 2007

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinte.167.2.188

Subject(s) - medicine , confidence interval , odds ratio , hazard ratio , hip fracture , osteoporosis , depression (economics) , population , cohort study , fragility , environmental health , chemistry , economics , macroeconomics

Depression and osteoporotic fractures are common ailments among elderly persons. Selective serotonin reuptake inhibitors (SSRIs) are frequently used in the treatment of depression in this population, and the association between daily SSRI use and fragility fractures is unclear. Our objective was to examine the effect of daily SSRI use on the risk of incident clinical fragility fracture.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research